From Yahoo Finance.: 2025-05-09 10:11:00

Baron Funds released its first quarter 2025 investor letter for the “Baron Health Care Fund,” which returned 2.54% (Institutional Shares) compared to a 3.87% gain for the Russell 3000 Health Care Index and a 4.72% decline for the Russell 3000 Index. The fund trailed the benchmark due to stock selection and active sub-industry weights.

Masimo Corporation (NASDAQ: MASI) is a medical technology company highlighted in the Baron Health Care Fund’s Q1 2025 investor letter. Masimo’s one-month return was -0.21%, and its shares gained 26.13% over the last 52 weeks. On May 8, 2025, Masimo Corporation stock closed at $153.58 per share with a market capitalization of $8.327 billion.

In the Q1 2025 investor letter, Baron Health Care Fund initiated a position in Masimo Corporation, a market leader in pulse oximetry technology used in top U.S. hospitals. Masimo’s differentiated technology maintains accuracy in the presence of motion and low perfusion, with significant intellectual property protection and a highly recurring revenue model driven by disposable sensors.

Masimo Corporation’s revenue grew 10% to $372 million in the first quarter of 2025. While acknowledging its potential as an investment, Baron Funds believe AI stocks hold greater promise for higher returns within a shorter timeframe. The fund also noted that Masimo Corporation is not among the 30 most popular stocks among hedge funds, with 35 hedge fund portfolios holding the stock at the end of the fourth quarter.

For more investor letters from hedge funds and leading investors, visit the hedge fund investor letters Q1 2025 page. No disclosure was provided in the article, which was originally published on Insider Monkey.



Read more at Yahoo Finance.: Do You Believe in the Growth Potential of Masimo Corporation (MASI)?